Skip to main content
SpringerLink
Log in

Models for evaluating compounds for activity againstPneumocystis carinii

  • Current Topic: Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Cultures and animal models have been developed to provide reproducible and uniform systems for evaluation of compounds for effects onPneumocystis carinii. The culture model allows rapid low-cost screening of drugs for activity against trophozoite forms. The animal models allow testing of efficacy for prophylaxis and therapy ofPneumocystis carinii pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bartlett MS, Verbanac PA, Smith JW Cultivation ofPneumocystis carinii with WI-38 cells. Journal of Clinical Microbiology 1979, 10: 796–799.

    PubMed  Google Scholar 

  2. Bartlett MS, Queener SF, Jay MA, Durkin MM, Smith JW Improved rat model for studyingPneumocystis carinii pneumonia. Journal of Clinical Microbiology 1987, 25: 480–484.

    PubMed  Google Scholar 

  3. Bartlett MS, Fishman JA, Durkin MM, Queener SF, Smith JW Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis ofPneumocystis pneumonia in the rat (Rattus spp.). Experimental Parasitology 1990, 70: 100–106.

    PubMed  Google Scholar 

  4. Queener SF, Bartlett MS, Richardson JD, Durkin MM, Jay MA, Smith JW Activity of clindamycin and primaquine againstPneumocystis carinii in vitro and in vivo. Antimicrobial Agents and Chemotherapy 1988, 32: 807–813.

    PubMed  Google Scholar 

  5. Queener SF, Bartlett MS, Jay MA, Durkin MM, Smith JW Activity of lipid-soluble inhibitors of dihydrofolate reductase againstPneumocystis carinii in culture and a rat model of infection. Antimicrobial Agents and Chemotherapy 1987, 31: 1323–1327.

    PubMed  Google Scholar 

  6. Smith JW, Bartlett MS, Queener SF, Durkin MM, Jay MA, Hull MT, Klein RS, Marr JJ Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagnostic Microbiology and Infectious Diseases 1987, 7: 113–118.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Division of Clinical Microbiology, Indiana University School of Medicine, 926 West Michigan Street, 46202-5250, Indianapolis, Indiana, USA

    M. S. Bartlett

Authors
  1. M. S. Bartlett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartlett, M.S. Models for evaluating compounds for activity againstPneumocystis carinii . Eur. J. Clin. Microbiol. Infect. Dis. 10, 199–201 (1991). https://doi.org/10.1007/BF01964463

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964463

Keywords

Search

Navigation